{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:21:17Z","timestamp":1767918077737,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010586","name":"Haukeland\u00a0Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016190","name":"Trond Mohn stiftelse","doi-asserted-by":"publisher","award":["BFS2017NUTRITIONLAB"],"award-info":[{"award-number":["BFS2017NUTRITIONLAB"]}],"id":[{"id":"10.13039\/100016190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajcnut.2023.04.033","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:14:25Z","timestamp":1682680465000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-8165","authenticated-orcid":false,"given":"Indu","family":"Dhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gard FT.","family":"Svingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen \u00d8.","family":"Bj\u00f8rnestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arve","family":"Ulvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahrai","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottar K.","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajcnut.2023.04.033_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.mpmed.2022.04.011","article-title":"Drugs for systemic hypertension and angina","volume":"50","author":"Waller","year":"2022","journal-title":"Medicine"},{"issue":"9437","key":"10.1016\/j.ajcnut.2023.04.033_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajcnut.2023.04.033_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2008.09.043","article-title":"Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis","volume":"122","author":"Bangalore","year":"2009","journal-title":"Am. J. Med."},{"issue":"18","key":"10.1016\/j.ajcnut.2023.04.033_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","article-title":"\u03b2-Blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","volume":"40","author":"Sorbets","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ajcnut.2023.04.033_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archinte.1993.00410030053008","article-title":"Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study","volume":"153","author":"Goldbourt","year":"1993","journal-title":"Arch. Intern. Med."},{"issue":"15","key":"10.1016\/j.ajcnut.2023.04.033_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","article-title":"Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies","volume":"67","author":"Yusuf","year":"1991","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ajcnut.2023.04.033_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajcnut.2023.04.033_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/1755-5922.12064","article-title":"The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease","volume":"32","author":"Debreceni","year":"2014","journal-title":"Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.ajcnut.2023.04.033_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/joim.13279","article-title":"Homocysteine \u2013 from disease biomarker to disease prevention","volume":"290","author":"Smith","year":"2021","journal-title":"J.\u00a0Intern. Med."},{"issue":"12","key":"10.1016\/j.ajcnut.2023.04.033_bib10","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1016\/j.clinthera.2021.10.002","article-title":"The effects of folic acid supplementation on pro-inflammatory mediators: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"43","author":"Zargarzadeh","year":"2021","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.ajcnut.2023.04.033_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2007.02506.x","article-title":"Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients","volume":"5","author":"Manrique","year":"2007","journal-title":"J.\u00a0Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.ajcnut.2023.04.033_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00005344-200206000-00010","article-title":"Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers","volume":"39","author":"Mayer","year":"2002","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.ajcnut.2023.04.033_bib13","first-page":"2874","article-title":"Different doses of folic acid and vitamin B12 to treat rabbits with deep venous thrombosis and hyperhomocysteinemia","volume":"15","author":"Shu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.ajcnut.2023.04.033_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.HYP.11.4.387","article-title":"Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat","volume":"11","author":"Paulose","year":"1988","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ajcnut.2023.04.033_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ajcnut.2023.04.033_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajcnut.2023.04.033_bib17","first-page":"33","article-title":"Serum homocysteine in men with controlled hypertension taking dihydropyridine calcium channel blockers","volume":"19","author":"Tatar","year":"2002","journal-title":"J.\u00a0Biol. Med."},{"issue":"4","key":"10.1016\/j.ajcnut.2023.04.033_bib18","first-page":"219","article-title":"Effect of antihypertensive drugs on homocysteine level among hypertensive patients","volume":"8","author":"Rawat","year":"2018","journal-title":"Asian J. Res. Pharm. Sci."},{"issue":"17","key":"10.1016\/j.ajcnut.2023.04.033_bib19","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/01.CIR.99.17.2276","article-title":"Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-\u03baB in primary human vascular smooth muscle cells","volume":"99","author":"Eickelberg","year":"1999","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ajcnut.2023.04.033_bib20","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0022-2828(95)91803-5","article-title":"Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells","volume":"27","author":"R\u00f6dler","year":"1995","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.ajcnut.2023.04.033_bib21","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-8703(99)70368-6","article-title":"Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension","volume":"137","author":"Sakata","year":"1999","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ajcnut.2023.04.033_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/hc0402.102929","article-title":"Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1","volume":"105","author":"Pahor","year":"2002","journal-title":"Circulation"},{"issue":"Suppl F","key":"10.1016\/j.ajcnut.2023.04.033_bib23","first-page":"F27","article-title":"Effect of calcium antagonists on sympathetic activity","volume":"19","author":"Grossman","year":"1998","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ajcnut.2023.04.033_bib24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/ATVBAHA.113.301714","article-title":"Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris","volume":"33","author":"Svingen","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.ajcnut.2023.04.033_bib25","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.ajcnut.2023.04.033_bib26","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"issue":"446","key":"10.1016\/j.ajcnut.2023.04.033_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J.\u00a0Am. Stat. Assoc."},{"issue":"5","key":"10.1016\/j.ajcnut.2023.04.033_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.56.5.400","article-title":"Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both","volume":"56","year":"1986","journal-title":"Br. Heart J."},{"issue":"1","key":"10.1016\/j.ajcnut.2023.04.033_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF03391603","article-title":"Folic acid and vitamin B12 forti\ufb01cation of \ufb02our: a global basic food security requirement","volume":"32","author":"Oakley","year":"2010","journal-title":"Public Health Rev"},{"issue":"12","key":"10.1016\/j.ajcnut.2023.04.033_bib30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/eci.12553","article-title":"Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications","volume":"45","author":"Grassi","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.ajcnut.2023.04.033_bib31","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1161\/01.CIR.0000070983.15903.A2","article-title":"Beta-adrenergic blockers","volume":"107","author":"Frishman","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajcnut.2023.04.033_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ajcnut.2023.04.033_bib33","first-page":"14","article-title":"Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?","volume":"12","author":"Reiss","year":"2017","journal-title":"Clin. Lipidol"},{"key":"10.1016\/j.ajcnut.2023.04.033_bib34","doi-asserted-by":"crossref","unstructured":"J.M. Edelberg, C.F. Reilly, S.V. Pizzo, The inhibition of tissue type\u00a0plasminogen activator by plasminogen activator inhibitor-1. The\u00a0effects\u00a0of\u00a0fibrinogen, heparin, vitronectin, and lipoprotein(a), J. Biol.\u00a0Chem. 266(12) (199) 7488\u20137493. doi: 10.1016\/S0021-9258(20)89472-1.","DOI":"10.1016\/S0021-9258(20)89472-1"},{"issue":"19","key":"10.1016\/j.ajcnut.2023.04.033_bib35","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/euhj.2000.2148","article-title":"Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality","volume":"21","author":"Erikssen","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ajcnut.2023.04.033_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/978-3-030-12457-1_25","article-title":"Calcium channels and calcium-regulated channels in human red blood cells","volume":"1131","author":"Kaestner","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"16","key":"10.1016\/j.ajcnut.2023.04.033_bib37","doi-asserted-by":"crossref","first-page":"41G","DOI":"10.1016\/0002-9149(90)90394-G","article-title":"Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction","volume":"66","author":"Barger","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ajcnut.2023.04.033_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/07853890.2017.1366041","article-title":"Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis","volume":"49","author":"Chistiakov","year":"2017","journal-title":"Ann. Med."},{"issue":"16","key":"10.1016\/j.ajcnut.2023.04.033_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl6364","article-title":"On vasa vasorum: a history of advances in understanding the vessels of vessels","volume":"8","author":"Phillippi","year":"2022","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ajcnut.2023.04.033_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2796.2007.01810.x","article-title":"Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease","volume":"262","author":"Bleie","year":"2007","journal-title":"J.\u00a0Intern. Med."},{"issue":"9026","key":"10.1016\/j.ajcnut.2023.04.033_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","article-title":"Calcium-channel blockade and incidence of cancer in aged populations","volume":"348","author":"Pahor","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ajcnut.2023.04.033_bib42","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.160.12.1849","article-title":"Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding","volume":"160","author":"Kaplan","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"6982","key":"10.1016\/j.ajcnut.2023.04.033_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.310.6982.776","article-title":"Surgical bleeding: unexpected effect of a calcium antagonist","volume":"310","author":"Wagenknecht","year":"1995","journal-title":"BMJ"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523488910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523488910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:09:14Z","timestamp":1762078154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523488910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0002916523488910"],"URL":"https:\/\/doi.org\/10.1016\/j.ajcnut.2023.04.033","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajcnut.2023.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}]}}